As an initial step in evaluating the role of tumor suppressor genes in leukemogenesis, we surveyed primary leukemia cells from 130 patients for possible deletion of the retinoblastoma susceptibility (Rb) gene by Southern blot analysis. Two of them clearly showed homozygous deletion of Rb alleles. The first patient was a pre-6 acute lymphoid leukemia (ALL) associated with a cytogenetic translocation: t(14;16)(q24;q22). The deletion was located at the 3' portion of the Rb gene. very close to the site of Rb gene ECENT STUDIES have provided strong evidence to R support the proposal that loss of a certain key gene is a critical step in neoplastic transformation. The retinoblastoma susceptibility (Rb) gene, located in the chromosome 13 q14 region, is the prototype for such a class of recessive human cancer genes.' Inactivation of the R b gene has been demonstrated not only in human retin~blastoma~.~ but also in some cases of osteogenic sarcoma$5 breast carcinoma,6.' and small-cell lung cancer.' Furthermore, after introduction of the exogenous R b gene into retinoblastoma cells, most Rb-reconstituted tumor cells exhibit changes in morphology, have slower growth rates, and lose tumorigenicity in nude mice.' This demonstration of neoplastic phenotype suppression by a single gene provides direct evidence concerning the essential role of R b gene loss in certain types of cancer.
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The R b gene product is characterized as a nuclear phosphoprotein of 1 10 Kd associated with DNA binding activity." Recent data suggest that the R b gene product is ubiquitously expressed in normal human cells and that it may function as a cell cycle regulator. R b protein appears to block transition of normal cells from GO/G1 into S phase."*'' This block can be transiently released by phosphorylation of the R b protein,I2 or permanently released by formation of a complex with certain viral-transforming proteins such as SV40 T antigen,13 adenovirus E 1 A protein,I4 or human papillomavirus E7 oncop r~t e i n . '~ The R b gene product is also expressed in human hematopoietic cells and is associated with cell cycle control and terminal differentiation.I6 Thus, dysfunction of the R b gene may play a role in the oncogenesis of certain hematologic malignancies. To study this possibility, we examined the DNAs from primary human leukemias to seek any abnormality in Rb alleles.
MATERIALS AND METHODS
Mononuclear cells were obtained from bone marrow (BM) aspirate by Ficoll-Hypaque centrifugation at the time of diagnosis and immediately saved in liquid nitrogen until use. Each sample contained more than 75% malignant cells. Diagnosis was based on characteristics of cell morphology, cytochemical staining, and results to a panel of monoclonal antibodies (MoAbs), including common acute lymphoid leukemia (ALL) antigen (CALLA) and terminal deoxynucleotidyl transferase (TdT). Cytogenetic studies were also performed by the G-banding method as described elsewhere. '
Analysis of DNA was undertaken from 130 samples obtained from patients with leukemias, including 9 chronic myelogenous leukemia, 52 ALL, and 69 acute nonlymphoid leukemia (ANLL). Among these patients, three with ANLL had a preceding history of myelodysplastic syndrome.
DNA isolation, restriction endonuclease digestion of DNA samples, agarose gel electropheresis, Southern blotting, and hybridization were all performed as previously described.Is DNA probes of the Rb gene (provided by Dr W. H. LeeI9) consisted of p0.9R containing the 5' exons and p3.8R for the 3'exons. For internal control of sample DNA quality, N-ras cDNA clone was obtained from American Type Culture Collection (ATCC no. 41031, pNRSac) and an EcoRI-Hind111 fragment hybridizing to exon 2 was further gel purified as a probe.
Identification of Rb protein and actin was performed by immunoprecipitation and subsequent Western blot analysis as described previously.*' Cells (5 x IO') were lysed at 4OC with 1 mL lysis buffer [50 mmol/L Tris-HC1 (pH 8.0)], 0.25 mol/L NaCl, 0.1% Nonidet P-40, 5 mmol/L EDTA, 50 pg/mL aprotinin, and 1 mmol/L phenylmethylsulfonylfluoride (PMSF)]. After clarification, the supernatants were first incubated with PMG 3-245 mouse anti-human Rb-protein MoAb (PharMingen, San Diego, CA) (200 &mL) or as an internal control with mouse anti-human actin antibody at 4OC for 1 hour. They were subsequently reacted with rabbit anti-mouse IgG (Jackson Immuno-research Laboratories, West Grove, PA) (400 pg/mL) and then with protein A-Sepharose beads (Pierce, Rockford, IL).
After centrifugation, the beads were washed twice and bound proteins were freed by heating at 100°C for 10 minutes. The immunoprecipitated proteins were separated in an 8% sodium dodecyl sulfate (SDS)-polyacrylamide gel and then transferred to Immobilon membranes (Millipore, Bedford, MA). After overnight blocking in Tris-buffered saline with 0.05% Tween 20 (TBST) with 4% skim milk and 0.1% sodium azide, the Immobilon membranes were probed again with MoAb PMG 3-245 or antiactin MoAbs for 3
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RESULTS
Gross structural deletions within the Rb gene were detected by Southern blot procedure in two patients with primary leukemias. Patient I was a 75-year-old woman. The diagnosis of pre-B ALL was further characterized by the cytogenetic abnormality t( 14;16)(q24;q22) and gene rearrangements of both immunoglobulin heavy chain and T-cell receptor-@ (TCR-@) chain (Table 1) .
Southern blot analysis of DNA from patient I. as compared with a normal control, demonstrated a remarkably reduced intensity at the 10.0-, 6.2-, and 2.1-kilobase (kb) Hindlll fragments and moderately reduced the intensity of the 5.5-kb band; that of the 7.5-and 4.5-kb bands appeared to be equal (Fig 1 A, lane 1 v lane 2 ). Deletions were again noted when DNA from this specimen was digested with BomHI, (Fig IC, lane 1 v lane 2) or EcoRI, (Fig IC, lane 3 v lane 4). On the other hand, the DNA blot analysis probed with p0.9R showed equal density for all the 5' fragments ( Fig  IB) in this patient. To ensure that the sample DNA was not degraded, the same blot was hybridized with N-rus probe (detecting only exon 2). syndrome." but some investigators have claimed that CM-MOL has distinctive hematologic features and evolution, thus justifying its separation from other subtypes of myelodysplastic syndrome.'' The patient achieved good partial remission after treatment with low-dose cytosine arabinoside (20 mg/m2 per day, 24-hour infusion). She developed blastic transformation 8 months later, and subsequently died ( Table   1 ) .
From patient 11, two DNA specimens were analyzed, one at diagnosis of CMMoL and one at blastic transformation. In intensity of a normal 7.5-kb band was also noted when a p3.8R probe was used (Fig 3A, lane 1 v lane 2) . The deletion was demonstrated again in DNAs restricted with EcoRl ( Fig  3C, lane 1 v lane 2) and &!I1 (Fig 3C, lane 3 v lane 4) . These abnormalities were no longer present when the DNA specimen obtained at blastic transformation was studied, however: normal patterns were noted with either a p3.8R ( Fig  3A. lane 1 v lane 3) or a p0.9R probe (Fig 3B, lane 1 v lane  3) . Therefore, the 5' portion of Rb gene was deleted in leukemic cells at CMMoL stage. To show that the deletion was not an artifact for degraded samples, the blot was rehybridized with probe pNRSac and the sample DNA appeared to be intact (Fig 3A, bottom) . In this instance. Rb protein analysis was not performed because leukemic cells were insufficient.
DISCUSSION
The results of the present studies indicated that gross deletion of Rb gene was present in a small percentage of patients with primary leukemias. The extent of the deletions present in these two patients is shown in Fig 4. In patient I, the absence of 2.1-, 6.2-. and 10.0-kb Hindlll restriction fragments, normally detected by the probe p3.8R, indicated homozygous deletion at the 3' portion of the Rb gene. The decreased intensity of the 5.5-kb band was considered to result from loss of the 5.3-kb fragment which usually superimposes on the 5.5-kb band. Deletion of the Rb gene in this patient was proposed, as shown in Fig 4, with the breakage point around intron 17. the most frequent breaking site in retinoblastomas." Intron 17 is also the largest, which may account for failure to detect a new junctional fragment. Rb gene dysfunction in this patient was further supported by the absence of Rb protein in leukemic cells (Fig 2) .
Patient I1 had another deletion pattern with a homozygous deletion of the 14.0-kb fragment at the 5' end of the Rbgene. In addition, a heterozygous deletion of a 7.5-kb fragment (as shown in Fig 4) was considered, after the corresponding bands in the DNA blot analysis were quantitated by densitometer scanning (data not shown).
The Rb gene product is a nuclear phosphoprotein of I IO Kd that serves as a regulator of cell cycle control and terminal differentiation. That R b protein is detectable in the normal retinoblasts but is not detectable in nearly 100% of the retinoblastoma cell lines or retinoblastomas strongly supports the concept that R b inactivation may be central to genesis of all retinoblastoma^.^^ In the present studies, R b protein synthesis was demonstrated in leukemic cells without R b gene abnormality (Fig 2, lane 2) yet was definitely absent in patient I (Fig 2, lane 3) and probably in patient I1 (although there were too few leukemic cells for study). Whether the R b gene deletion is, related to leukemogenesis in these two patients, as in retinoblastoma, is questionable.
Patient I, in addition to having the R b gene deletion, was remarkable in that she had a translocation involving chromosome 14 and chromosome 16 as well as coexistence of gene rearrangements of immunoglobulin heavy chain and TCR-/3 chain. Chromosome 14 contains loci for immunoglobulin heavy chain, TCR-a and T C R d chains; cytogenetic abnormalities of chromosome 14 are frequently detected with both the B-and T-lineage lymphoma/leukemia. Consequently, such a rearrangement is usually considered an extremely important event in development of these lymphoid malignan~i e s . '~ The present results suggested that apart from this, loss of tumor suppression genes may also participate in the leukemogenesis. Recently an ALL cell line (HSB-2) has been found to have an R b gene deletionz6 a t a site very close to that of patient I. This finding not only strengthens the speculation, but even suggests that R b gene deletion plays a significant role in certain types of ALL.
Demonstration of an R b gene deletion of patient I1 a t the CMMoL stage but not in the phase of acute blastic transformation has provided interesting information about the clonality switch in the evolution of leukemia in this patient. It suggests that one line, evolved from the original leukemic cell, became dominant a t the chronic stage, probably a consequence of acquiring an R b deletion. At the stage of blastic transformation, however, a different line with an intact R b gene quickly outgrew, and finally took over the one with an R b gene deletion. This observation indicated that loss of an R b gene is a somatic event in the evolution of leukemia.
The present study is retrospective; therefore, adequate controls (such as patients' fibroblast DNAs) or samples (for Northern analysis) are not available. Further and more complete studies are required. The preliminary results demonstrated R b gene deletion in a small percentage of human primary leukemias. However, gross rearrangement or deletion is responsible for less than one third of the gene inactivation events. Much more frequent are subtle changes, such as point mutations, not detected by Southern blot a n a l y s i~.~~~~~ In the present study, although only 2 of 130 primary human leukemias were shown by DNA blot analysis studies to have a deletion of the R b gene, a much higher frequency of R b gene inactivation in leukemic patients may be expected if R N A transcripts or R b protein is systematically examined. We hope that such studies may pave the way for understanding the role played by the R b gene in leukemia.
